|Analysis of 13 cell types reveals evidence for the expression of numerous novel primate-and tissue-specific microRNAs|
E Londin, P Loher, AG Telonis, K Quann, P Clark, Y Jing, E Hatzimichael, ...
Proceedings of the National Academy of Sciences 112 (10), E1106-E1115, 2015
|MEG3 imprinted gene contribution in tumorigenesis|
L Benetatos, G Vartholomatos, E Hatzimichael
International journal of cancer 129 (4), 773-779, 2011
|The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis|
L Benetatos, E Hatzimichael, E Londin, G Vartholomatos, P Loher, ...
Cellular and molecular life sciences 70 (5), 795-814, 2013
|CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes|
L Benetatos, E Hatzimichael, A Dasoula, G Dranitsaris, S Tsiara, M Syrrou, ...
Leukemia research 34 (2), 148-153, 2010
|The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman’s disease|
T Powles, J Stebbing, A Bazeos, E Hatzimichael, S Mandalia, M Nelson, ...
Annals of oncology 20 (4), 775-779, 2009
|The role of cytokines in sickle cell disease|
AC Makis, EC Hatzimichael, KL Bourantas
Annals of hematology 79 (8), 407-413, 2000
|Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents|
MA Dimopoulos, S Delimpasi, E Katodritou, A Vassou, MC Kyrtsonis, ...
Annals of oncology 25 (1), 195-200, 2014
|Hematopoietic stem cell transplantation|
E Hatzimichael, M Tuthill
Stem cells and cloning: advances and applications 3, 105, 2010
|Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma|
N Syed, J Langer, K Janczar, P Singh, CL Nigro, L Lattanzio, HM Coley, ...
Cell death & disease 4 (1), e458-e458, 2013
|Serum interleukin (IL)‐1, IL‐2, sIL‐2Ra, IL‐6 and thrombopoietin levels in patients with chronic myeloproliferative diseases|
KE Panteli, EC Hatzimichael, PK Bouranta, A Katsaraki, K Seferiadis, ...
British journal of haematology 130 (5), 709-715, 2005
|Cancer epigenetics: new therapies and new challenges|
E Hatzimichael, T Crook
Journal of drug delivery 2013, 2013
|Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis|
B Delage, P Luong, L Maharaj, C O’riain, N Syed, T Crook, ...
Cell death & disease 3 (7), e342-e342, 2012
|Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma|
L Benetatos, A Dasoula, E Hatzimichael, I Georgiou, M Syrrou, ...
Clinical Lymphoma and Myeloma 8 (3), 171-175, 2008
|Revisiting bleomycin from pathophysiology to safe clinical use|
M Froudarakis, E Hatzimichael, L Kyriazopoulou, K Lagos, P Pappas, ...
Critical reviews in oncology/hematology 87 (1), 90-100, 2013
|Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients|
C Sfagos, AC Makis, A Chaidos, EC Hatzimichael, A Dalamaga, K Kosma, ...
Multiple Sclerosis Journal 11 (3), 272-275, 2005
|Non‐coding RNAs and EZH2 interactions in cancer: long and short tales from the transcriptome|
L Benetatos, E Voulgaris, G Vartholomatos, E Hatzimichael
International journal of cancer 133 (2), 267-274, 2013
|NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity|
H Wang, S Lee, CL Nigro, L Lattanzio, M Merlano, M Monteverde, R Matin, ...
British Journal of Cancer 106 (8), 1446-1452, 2012
|Gene mutations and molecularly targeted therapies in acute myeloid leukemia|
E Hatzimichael, G Georgiou, L Benetatos, E Briasoulis
American journal of blood research 3 (1), 29, 2013
|The human platelet: strong transcriptome correlations among individuals associate weakly with the platelet proteome|
ER Londin, E Hatzimichael, P Loher, L Edelstein, C Shaw, K Delgrosso, ...
Biology direct 9 (1), 1-12, 2014
|Clinical trial design in biosimilar drug development|
G Dranitsaris, K Dorward, E Hatzimichael, E Amir
Investigational new drugs 31 (2), 479-487, 2013